1. Incidence of skeletal related events in patients with bone metastasis receiving denosumab every four weeks compared to intervals greater than every four weeks. (April 2019) Authors: Yerram, Prakirthi; Moore, Russell; Wolf, Steven; Barbour, Sally Y Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 3(2019) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗